- Date 20 Apr 2021
Each year, The Medicine Maker publishes its Power List – recognising “the inspirational minds that contribute to the development and manufacture of groundbreaking new medicines, including small molecules, biopharmaceuticals, and advanced therapies”.
Will Downie, Vectura’s CEO, has made the Small Molecules category of this year’s list which features just 20 leaders, including some of the biggest names in pharmaceutical developmentand the CDMO sector.
Asked to comment on the impact of COVID-19 on the pharma industry, Will told the magazine: “Often, out of a crisis, great things happen. This is clearly a moment in time where the world has faced one of its biggest challenges, with the pharma industry playing a central role in fighting the pandemic.
You might also be interested in these articles
Steaming up Success: ARU student’s path from café to creativity
We recently did a Q&A session with Anglia Ruskin student Soorya Jith, who started his journey as a Barista at the Lakeside Café within the Bradfield Centre on Cambridge Science Park. He has now transitioned to Krank, also located on the Park, as a Junior Graphic Designer.
Sun 21 Apr 2024
Cambridge Science Park
Cambridge Future Tech Expands its Board with the Appointment of Michael Beer and Jem Davies as Non-Executive Directors
Leading DeepTech Venture-Builder Further Strengthens its Unique Position to Cultivate Innovative Technologies with the Addition of Seasoned Industry Professionals
Sun 14 Apr 2024
Cambridge Future Tech
Xampla welcomes former P&G chemist to team as scale-up accelerates
accelerates CREATOR of plastic-free, natural materials, Xampla, continues to scale-up the commercialisation of its biodegradable Morro materials with new industry hire.
Fri 1 Mar 2024
Xampla Ltd
